INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-2 AND PROTEIN-3 STIMULATE GROWTH-HORMONE RECEPTOR-BINDING AND MITOGENESIS IN RAT OSTEOSARCOMA CELLS

被引:60
作者
SLOOTWEG, MC
OHLSSON, C
SALLES, JP
DEVRIES, CP
NETELENBOS, JC
机构
[1] FREE UNIV AMSTERDAM HOSP,RES INST ENDOCRINOL,1007 MB AMSTERDAM,NETHERLANDS
[2] SAHLGRENS UNIV HOSP,ENDOCRINOL & METAB RES CTR,S-41345 GOTHENBURG,SWEDEN
关键词
D O I
10.1210/en.136.10.4210
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
GH exerts its biological actions an osteoblasts through a specific high affinity receptor expressed on these cells. GH receptor binding is positively modulated by a number of factors, including retinoic acid and dexamethasone, whereas fetal calf serum strongly decreases the binding. To identify responsible factors in serum, components of serum, the insulin-like growth factors (IGFs)-I and -II, and IGF binding proteins (IGFBPs)-2 and -3 were tested for a possible negative modulatory role. IGF-I and -II decreased [I-125]hGH binding at an optimal concentration of 30 ng/ml for IGF-I and 100 ng/ml IGF-II, reducing the binding to 51% and 55%, respectively, of control values. A stimulation of [I-125]hGH binding was observed with IGFBP-2 as well as IGFBP-3, inducing an increase to 148% and 151% of control binding at an optimal concentration of 3000 ng/ml for both peptides. The effects of all peptides were dependent on the incubation time, being significantly increased after 8 h of incubation and reaching the full effect thereafter. The effects were declined at 24 h compared with 16 h for IGFBP-2 and -3 but not for IGF-I and -II. Coincubation of the cells with TGF-I and -II and IGFBP-2 and -3 neutralized the effects of the factors alone. In conclusion, these results show that IGF-I and -II on the one hand and IGFBP-2 and -3 on the other hand exert opposite actions on [I-125]hGH binding, IGFBP-5 and -3 exerting probably an IGF-independent effect. Further, IGF-I and -II decreased GH receptor messenger RNA (mRNA) levels, as quantified by a solution hybridization ribonuclease protection assay, from 8.65 +/- 1.78 attomoles (amol)/mu g DNA (control) to 2.4 +/- 0.68 and 2.16 +/- 0.92 amol/mu g DNA, respectively. IGFBP-5 increased GH receptor mRNA levels from 5.26 +/- 1.17 (control) to 18.19 +/- 3.48. Incubation with IGFBP-3 did not result in stimulation of GH receptor mRNA levels (8.59 +/- 2.91 amol/mu g DNA). This shows that the mechanism of regulation of the GH receptor is, except for IGFBP-3, at least in part on the mRNA level. Lastly, IGFBP-2 and IGFBP-3 are mitogenic for UMR-106.01 rat osteosarcoma cells, inducing an increase in cell number to 125% and 142% of control cell counts after 48 h of incubation with 1000 ng/ml IGFBP-2 and -3, whereas IGF-I, IGF-II and Long R(3) IGF-I did not stimulate proliferation. IGFBP-2 and -3 potentiate hGH induced mitogenesis at low hGH concentrations of both factors, whereas at higher concentrations no such effect is observed. IGF-I and -II inhibit hGHs action. The physiological relevance of GH receptor modulation is a subject of investigation at the present time.
引用
收藏
页码:4210 / 4217
页数:8
相关论文
共 50 条
[21]   STRUCTURE OF THE HUMAN INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-2 GENE [J].
BINKERT, C ;
MARGOT, JB ;
LANDWEHR, J ;
HEINRICH, G ;
SCHWANDER, J .
MOLECULAR ENDOCRINOLOGY, 1992, 6 (05) :826-836
[22]   CLINICAL UTILITY OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 IN THE EVALUATION AND TREATMENT OF SHORT CHILDREN WITH SUSPECTED GROWTH-HORMONE DEFICIENCY [J].
HASEGAWA, Y ;
HASEGAWA, T ;
ASO, T ;
KOTOH, S ;
NOSE, O ;
OHYAMA, Y ;
ARAKI, K ;
TANAKA, T ;
SAISYO, S ;
YOKOYA, S ;
NISHI, Y ;
MIYAMOTO, S ;
SASAKI, N ;
KURIMOTO, F ;
STENE, M ;
TSUCHIYA, Y .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1994, 131 (01) :27-32
[23]   GROWTH-HORMONE, BUT NOT INSULIN-LIKE GROWTH FACTOR-I, INDUCES A SERUM PROTEASE ACTIVITY FOR INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 IN HYPOPHYSECTOMIZED RATS IN-VIVO [J].
RUTISHAUSER, J ;
SCHMID, C ;
HAURI, C ;
FROESCH, ER ;
ZAPF, J .
FEBS LETTERS, 1993, 334 (01) :23-26
[24]   Promoting effect of insulin-like growth factor-I insulin-like growth factor binding protein-3 complex on osteosarcoma cells. [J].
Moriwake, T ;
Tanaka, H ;
Seino, Y .
JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 :T303-T303
[25]   INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 IS FUNCTIONALLY ALTERED IN PREGNANCY PLASMA [J].
LASSARRE, C ;
BINOUX, M .
ENDOCRINOLOGY, 1994, 134 (03) :1254-1262
[26]   STRUCTURAL AND BIOLOGICAL CHARACTERIZATION OF BOVINE INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 [J].
CONOVER, CA ;
RONK, M ;
LOMBANA, F ;
POWELL, DR .
ENDOCRINOLOGY, 1990, 127 (06) :2795-2803
[27]   ALTERED LIGAND SPECIFICITY OF PROTEOLYZED INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 [J].
BAXTER, RC ;
SKRIVER, L .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 196 (03) :1267-1273
[29]   Insulin-like growth factor binding protein-3: Insulin-like growth factor independence comes of age [J].
Cohen, P .
ENDOCRINOLOGY, 2006, 147 (05) :2109-2111
[30]   CHARACTERIZATION OF THE BINDING DEFECT IN INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 FROM PREGNANCY SERUM [J].
BAXTER, RC ;
SUIKKARI, AM ;
MARTIN, JL .
BIOCHEMICAL JOURNAL, 1993, 294 :847-852